FDA product code QNY: Remote Or Wearable Patient Monitoring Device For Drug Induced Qt Prolongation Monitoring

QNY is the FDA product code for remote or wearable patient monitoring device for drug induced qt prolongation monitoring. It is a Not classified device, reviewed by the Cardiovascular panel. Devices under QNY reach the market by PMA; FDA lists no cleared 510(k)s for it.

Definition

To be used by healthcare professionals (HCP) in the hospital setting for remote monitoring and detection of changes in the QT interval of an electrocardiogram (ECG) in general care patients who are 18 years of age or older and are undergoing treatment with drugs that can prolong QT intervals and may cause life threatening arrhythmias. Device used during declared public health emergency.

Classification

FieldValue
Device nameRemote Or Wearable Patient Monitoring Device For Drug Induced Qt Prolongation Monitoring
Device classNot classified
Review panelCV — Cardiovascular
Medical specialtyUnknown
Premarket routePMA

Recalls for QNY devices

FDA recall records list no recalls for product code QNY.

Frequently asked questions

What is FDA product code QNY?

QNY is the FDA product code for remote or wearable patient monitoring device for drug induced qt prolongation monitoring. It is a Not classified device, reviewed by the Cardiovascular panel.

What device class is QNY?

Not classified. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times